“…data on worldwide promethazine prescriptions) are not available, it was unclear if what observed was a substantial number of cases, indicative of clinically meaningful abuse potential, or a passing trend for promethazine misuse by a very small number of individuals. However, consistent with previous suggestions (Montastruc et al, 2011), the value of the current study was that its rationale was driven by a proper, detailed, Tellerup, 2018;NIDA, 2014;Page et al, 2009;Parker et al, 2013;Peters et al, 2007), most recorded ADRs related here to either 'drug abuse' and 'intentional product misuse', involving young adult (19-25 years) males. Although considered a vulnerable category with respect to prescription drug abuse (Agnich et al, 2013;Burns and Boyer, 2013;Cherian et al, 2018;NIDA, 2014;Peters et al, 2007), adolescents (10-18 years) were here reported in only a minority (23/1543:1.5%) of cases.…”